Prescribing for bladder and bowel Gillian Nottidge, Maria Moor Continence Nurse Specialists BDCT Aims of this session • Overview of incontinence • Medical management Cute Not so cute Facts and statistics • WHO report that bladder control problems affect more than 200m people worldwide and that it is “a largely preventable and treatable condition” • The NHS estimates that between 3 and 6 million people in the UK have some degree of urinary incontinence. • In the UK, 24% of older people are affected by urinary incontinence. • In institutional care, 30-60% are affected by urinary incontinence • A study in 2002 found that 32% of women in the UK, 34% in Germany, 32% in France and 15% in Spain had symptoms of urinary incontinence in the previous 30 days. Definition of Urinary Incontinence The complaint of any involuntary leakage of urine Abrams 2002 The psycho – social impact of incontinence • Work • Exercise • Travelling • Socialising / relationships • Anxiety • Depression The physical impact of incontinence • • • • • Increased risk of falls Skin problems Pressure ulcers Urinary tract infections Delayed discharge Environmental cost Types of Incontinence • • • • • Urge incontinence (Overactive bladder) Stress incontinence Overflow incontinence Constipation Faecal incontinence What is bladder overactivity? • It is the strong and sudden need to pass urine due to bladder spasms which may result in incontinence Why Does it Happen? • The bladder is a muscle that can hold around 500mls of urine. Around 200-300mls may get a sensation to urinate • Normal bladder: passing urine is under voluntary control • Overactive bladder: becomes increasingly involuntary – The bladder starts to contract driving a sudden and strong urge to pass urine, often with little warning Symptoms • • • • An urgent need to urinate The need to urinate often, 8 or more times a day Waking up to urinate 2 or more times a night The need to urinate even if you have just gone to the toilet • Taking many trips to the toilet only to urinate just a little bit each time • Leaking urine when you have the urge to urinate Risk factors for overactive bladder • Nervous system conditions can increase susceptibility – Diabetic Neuropathy – Multiple sclerosis – Stroke – Spinal cord Injury – Dementia – Parkinsons • Idiopathic Overactive bladder – No cause can be found • Obesity Management of OAB • Reduce caffeine intake • Minimise alcohol intake • Drink adequate amounts of healthy fluids • • • • Pelvic floor exercises Bladder retraining Avoid constipation Anticholinergic medication Non-medical prescribing • Examine the holistic needs of the patient. Is a prescription really necessary? • Consider the appropriate strategy • Consider the choice of product • Negotiate a contract and achieve concordance with the patient • Review the patient on a regular basis • Ensure record keeping is both accurate and up-todate • Reflect on your prescribing Physical and Psychological effects • • • • • Increased risk of falls Depression and anxiety Social isolation interpersonal relationships Decrease in sexual function Diagnosing Overactive Bladder • Thorough assessment to include:– Past medical history – Bladder diary for 3 days – Urine test – Post void residual ultrasound scan – Pelvic examination Behavioural Therapy • Supervised pelvic floor muscle training • Bladder training for 6 weeks (Nice 2006) • In combination with fluid and lifestyle advise • Understanding the causes and risk factors Anticholinergic Medication • • • • • • • Oxybutynin Tolterodine Fesoterodine Solifenacin Trospium Trospium XL Darifenacin How do they work? • block the neurotransmitter, acetylcholine in the central and the peripheral nervous system. • operate on the muscarinic acetylcholine receptors. • Muscarinic receptors in smooth muscle, especially gastro-intestinal system, eyes, brain • M3 receptors more specifically in bladder Therapeutic effects • • • • Reduces frequency Reduces urgency Reduces nocturia . Reduces urge incontinence Side effects • • • • • • Dry mouth Dry eyes/altered eye accommodation GI disturbances/increased gastric secretions Constipation Cognitive impairment Increased residual/urinary retention Contra-indications • • • • • • Pregnancy and lactation (no available data) Narrow-angle glaucoma Allergy Severe renal/hepatic impairment Urinary retention/high residuals Myasthenia gravis Interactions • Ketoconozole increases action of anticholinergic • Anticholinergics can reduce absorption of Levadopa Pros and cons of each drug • Oxybutynin • Oxybutynin patches Advantages Effective, cheap Licensed in <18s Better tolerated than oral Oxybutynin • Tolterodine Effective • Fesoterodine More effective Both doses same price Disadvantages Side effects Skin irritation cardiac side effects New drug so no long term data Pros and cons of each drug • • Trospium Trospium XL • Darifenacin • Solifenacin • Advantages Does not cross Blood/brain barrier Disadvantages bd dose 1 hour before food Does not cross Blood/brain barrier (label23) Tolerated in elderly Recommended in obesity 1 hour before food Does not cross blood/brain barrier Tolerated in elderly Selects M3 receptors availability Effective Minimal CNS s/e GI disturbances 10mg dose expensive So which drug? • NICE recommend Oxybutynin IR first line – Remember it is just a guideline • NHS spend is £80 million annually on 2nd line drugs for OAB – NICE make no recommendation re 2nd choice – Counsel re risks and benefits of each drug Price per 28 days • • • • • • • • • Oxybutynin IR Oxybutynin MR Oxybutynin patches Trospium bd Trospium XL Solifenacin Tolterodine Darifenacin Fesoterodine • • • • • • • • • £5.89-31.78 £10.29-£14.16 £27.20 £24.27 £23.05 £25.78-£33.52 £25.78-£30.56 £26.13 £25.78 Botox • Reduces symptoms • Minimal hospitalisation • Effective in neurogenic conditions • Not a single treatment • May need to selfcatheterise • Used off license STRESS INCONTINENCE “the complaint of involuntary leakage on effort or exertion, or on sneezing or coughing” (Abrams 2002) Symptoms of Stress Incontinence Small leak of urine on: • Coughing • Sneezing • Exercise • Getting up out of chair • Picking baby up Causes of Stress Incontinence • • • • • • Childbirth Obesity Chronic chest problems Prostatectomy Chronic constipation Weakened pelvic floor Management of Stress Incontinence • • • • • • • • Pelvic floor exercises Squeeze while you sneeze! Adequate fluids – avoid caffeine and alcohol Double voiding Electrical stimulation Urodynamics (Duloxetine) TVT sling procedure Duloxetine – the wonder drug? • is thought to work by increasing the tone of the urethral sphincter by its action on serotonin and noradrenaline in the spinal cord. • prevents re-absorption of serotonin and noradrenaline • used to treat moderate to severe stress incontinence Side effects • Dizziness and fatigue • Postural hypotension or fainting • Hypertension • Hyponatraemia drowsiness, confusion, muscle twitching or convulsions. • Nausea vomiting and diarrhoea • Dry mouth • Headache • Reduced libido or anorgasmia • Sweating • Tremor • Blurred vision • No data for use in pregnancy/lactation Atrophic vaginitis • • • • • Reduced oestrogen post menopause Vaginal dryness – pain on intercourse Vulval soreness and itching Increased risk of incontinence Increased risk of vaginal and urinary tract infection Atrophic vaginitis • Avoid shower gel, soap, talc • Wash and moisturise the vulva with Aqueous cream/Diprobase • Topical oestrogen – pessaries or cream • Lubricant for intercourse – Sylk Local oestrogen • Contraindications • History or risk of breast cancer • Pregnancy or planning pregnancy • Current or previous thrombosis • Abnormal LFTs • Sensitivity to product • • • • • Side effects Vaginal discharge/bleeding Headache Genital candiasis Breast tenderness or enlargement • Nausea Dribbling/Overflow Incontinence Symptoms • • • • • • • Hesitancy Poor flow Interrupted flow Post micturition dribble Frequency Urgency Nocturia • Urge incontinence • Urinary tract infections • Feeling of incomplete emptying • Large residual urine volume • Passive incontinence Dribbling/Overflow Incontinence Symptoms • • • • • • • Hesitancy Poor flow Interrupted flow Post micturition dribble Frequency Urgency Nocturia • Urge incontinence • Urinary tract infections • Feeling of incomplete emptying • Large residual urine volume • Passive incontinence Obstructive causes of overflow incontinence • • • • • Outflow Obstruction Enlarged Prostate Urethral Stricture Uterine Prolapse Constipation Neurogenic causes of overflow/ dribbling incontinence • Multiple Sclerosis • Parkinson's Disease • Spinal cord injury • Spina Bifida • Brain Injuries • Pelvic Surgery Management of Overflow • • • • • Double voiding Treat constipation Treat enlarged prostate or other obstruction Intermittent Self-catheterisation Long-term supra-pubic catheter Size matters ! BAUS (2004) guidelines – Size over 30g – MTOPS study says over 25g – PSA greater than 1.4 ng/ml in the absence of CaP Early intervention with 5-ARI – Can reduce need for surgery by about 50% – Has been shown to reduce risk of progression to acute retention by 55% Medical Management • Alpha-blocker Tamsulosin Doxazosin Alfuzosin • 5-alpha-reductase inhibitor Finasteride Dutasteride • Combined therapy (BAUS 2004) Combidart Alpha-blockers • • • • • Relax smooth muscle Relax bladder neck Improve flow more complete emptying Reduction in nocturia = reduction in falls Alpha-blockers – side effects • Postural hypotension or dizziness • Drowsiness • Tiredness • Headache • Irritability • Decrease in semen • Retrograde ejaculation • Stuffy or runny nose, nausea, • Pain in the arms and legs, • Weakness • Tamsulosin most selective 5-Alpha reductase inhibitors • Androgen blockade • Reduces prostate size • Used in male pattern baldness. (Only in America!) Side effects • erectile dysfunction • decreased libido • decreased volume of ejaculate • pain in the testicles • changes in the breasts eg. increased size, lumps, pain, or nipple discharge • • • • rash itching hives swelling of the lips and face • Tablets should not be handled by pregnant women Intermittent Self-Catheterisation • Intermittent catheterisation is far from being a modern idea. • Urology was probably the very first medical subspeciality Intermittent Self-Catheterisation Containment Products Other products The last resort Bowel problems • 6.5 million people in the UK with some form of bowel problem 1:10 (bladder & bowel foundation 2011) • Slow transit • Chronic constipation • Obstructed defaecation • Faecal incontinence Evacuatory disorders and constipation • Spend on laxatives in the UK is over £50 million per year. (Allen 2007) • Anal irrigation recommended by NICE (2007) Bowel management • • • • • • Diet and fluids Exercise if possible Osmotic laxatives Stimulant laxatives Suppositories/enemas Anal irrigation Macrogols • contains sodium bicarbonate, sodium chloride and potassium chloride • an inert substance that passes through the gut without being absorbed into the body. • increases the water content and volume of the stools in the bowel • electrolytes included to ensure that it works without causing the body to gain or lose significant amounts of sodium, potassium or water. Stimulant laxatives • • • • Bisocodyl, Senna speed up gut motility for occasional use only Griping pain Types of irrigation • Gravity feed cone system • Electrical pump system • Rectal catheter pump system Gravity feed cone system • • • • Qufora Patient holds cone in place Gravity assists flow of water Performed on toilet Water and faeces empty into toilet Pump Cone system • • • • Biotrol pump Patient holds cone in place Pump assists flow of water Performed on toilet Water and faeces empty into toilet Catheter system • • • • Peristeen Rectal catheter held in place by balloon Water pumped into bowel Performed on the toilet Water and faeces empty into toilet when balloon released Never teach irrigation to the following patients: • Acute inflammatory bowel • Severe cognitive impairment (unless disease tolerated and carer able • Known obstructing rectal to supervise/administer) or colonic mass • Pregnant or • Rectal or colonic surgical breastfeeding anastamosis within the last 6months Proceed with caution • Spinal cord injury at or above T6 – risk of autonomic dysreflexia – 1st two irrigations must be supervised • Unstable metabolic conditions – renal or liver disease • Physical or cognitive disability/mental or emotional disorder • Anorectal conditions that cause pain or bleeding (e.g anal fissure, 3rd degree haemorrhoids) Proceed with caution • Pregnant or planning pregnancy • Any bowel or abdominal surgery within the last 6 months • Acute diarrhoea • Anal fissure • Large haemorrhoids that bleed easily • Past pelvic radiotherapy which has caused bowel problems • Severe diverticular disease • Rectal medications for other diseases • Congestive cardiac failure • Anal surgery within the past 6 months Positive outcomes • • • • • Reduced toileting time Clean and quick Improved confidence Quality of life Check suitability first Thank you for listening Any Questions? Gillian Nottidge Continence Specialist Nurse 01274 322210 Gillian.nottidge@BDCT.nhs.uk